- Cardiovascular disease (CVD) remains the leading cause of mortality in type 2 diabetes (T2D). Better interventions are needed to mitigate the high lifetime risk for CVD in youth T2D.
- The obesity epidemic is steadily increasing worldwide, and high body mass index (BMI) is a major risk factor for cardiovascular diseases, diabetes, hypertension, musculoskeletal disorders, and also some cancers . Diets are generally unsuccessful . Bariatric surgery is today the main treatment for severe obesity . There is a strong interest in finding less invasive methods  and whether that preoperative weight loss improves surgery outcomes  and reduces perioperative complications .
- The question of whether pure metabolic surgery could be used in nonobese patients with type 2 diabetes has been considered. The objective of this study was to assess the comparative effects of the Billroth I (BI) and Billroth II (BII) reconstruction methods on remission of type 2 diabetes in nonobese patients undergoing subtotal gastrectomy for cancer.
- Despite increasing awareness within the medical community about the benefits of bariatric surgery for type 2 diabetes mellitus (T2DM), little is known about patients’ attitudes toward bariatric surgery as a treatment for T2DM. The objective of this study was to investigate the attitudes of individuals with T2DM and a body mass index of 30 to 40 kg/m2 concerning bariatric surgery for the treatment of T2DM.
- Despite increasing evidence about the beneficial effects of bariatric surgery, little is known about physicians' attitudes toward it as a treatment of type 2 diabetes. Our objective was to investigate physicians' attitudes about referring patients with type 2 diabetes for bariatric surgery.